Medical/Pharmaceuticals
Advanced Waste Management Solution for Hospitals
SYDNEY, May 22, 2024 /PRNewswire/ -- Smart waste management in hospitals has
been increasingly important for achieving the higher standards of safety and
environmental expectation required by patients and staff compared with other
sectors.
2024-05-22 07:00
3484
YS Biopharma Announces Results of Extraordinary General Meeting
GAITHERSBURG, Md., May 22, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseas...
2024-05-22 04:15
3839
Announcement of The Shaw Laureates 2024
HONG KONG, May 21, 2024 /PRNewswire/ --
2024-05-21 21:58
5217
Oncology Events in Poland Solidify Collaboration with NCCN
The National Comprehensive Cancer Network participates in meetings hosted by Maria Sklodowska-Curie National Research Institute of Oncology, the Polish Oncological Society, and Alliance for Innovation to advance work adapting proven cancer treatment guidelines forPoland. WARSAW, Poland, May 21, ...
2024-05-21 21:03
2061
New CAS BioFinder Discovery Platform empowers drug discovery scientists to reveal insights, drive innovation, and save time
Transformative new scientific information capabilities combine an unparalleled collection of curated science data with advanced predictive models to accelerate early-stage drug discovery innovation COLUMBUS, Ohio, May 21, 2024 /PRNewswire/ -- Today, CAS, a division of the American Chemical Socie...
2024-05-21 21:00
3355
Complete Genomics expands to East Coast with new Customer Experience Center in Greater Boston's Biotech Hub
The laboratory gives researchers a training ground for state-of-the-art DNBSEQ technology to further precision diagnostics and treatments SAN JOSE, Calif., May 21, 2024 /PRNewswire/ -- Complete Genomics, a pioneering genomic sequencing company, today announced theMay 22 opening of its Customer E...
2024-05-21 21:00
2521
Etiometry Awarded Frost & Sullivan's 2024 North American Enabling Technology Leadership Award for Leading Innovation in Clinical Decision Support Systems
Etiometry's solutions provide healthcare professionals with actionable intelligence, setting new benchmarks in critical care treatment. SAN ANTONIO, May 21, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the clinical decision support for critical care industry and, based on its findin...
2024-05-21 20:00
1962
Ractigen Therapeutics Secures FDA Fast Track Designation for RAG-01, a First-in-Class saRNA Therapy
SUZHOU, China, May 21, 2024 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, proudly announces that its flagship program, RAG-01, has been granted Fast Track Designation (FTD) by the U.S. Food and Drug Administration (FDA). This notable a...
2024-05-21 20:00
2255
Cali Biosciences Announces Publication of Successful Phase 2 Study Results in Hernia
SAN DIEGO, May 21, 2024 /PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinafter referred to as "Cali Biosciences"), a biotechnology company dedicated to the research and development of innovative drugs, announced publication of "CPL‑01, an investigational long‑acting ropivacaine, demonstrates saf...
2024-05-21 17:52
1512
RemeGen Completes Patient Enrollment in Two Phase III Clinical Trials Using Telitacicept for Treatment of IgA Nephropathy and Primary Sjögren's Syndrome
YANTAI, China, May 21, 2024 /PRNewswire/ -- RemeGen Co. Ltd.
2024-05-21 17:35
2624
Dignitana signs an exclusivity agreement for Japan with Konica Minolta
LUND, Sweden, May 21, 2024 /PRNewswire/ -- Dignitana has signed a new multi-year Distribution Agreement for technology market leaderKonica Minolta to be the exclusive provider of The DigniCap Scalp Cooling System inJapan. DigniCap Delta is an innovative medical device used by cancer centers to m...
2024-05-21 16:43
1915
BGI Team Successfully Reaches the Summit of Mount Everest
Sends the world's first ultrasound image and EEG data from the top of the world SHENZHEN, China, May 21, 2024 /PRNewswire/ -- BGI Group Chairman and Co-Founder,Wang Jian, and a scientific team from BGI today reached the summit of Mount Everest (Qomolangma) at 8,848.86 meters and, using handheld u...
2024-05-21 16:41
2079
NUS scientists discover a novel way of activating muscle cells' natural defences against cancer using magnetic pulses
This drug-free, non-invasive approach could open the doors for new developments in cancer therapy and cancer biomarker discovery SINGAPORE, May 21, 2024 /PRNewswire/ -- A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovation & Technolo...
2024-05-21 16:35
2163
Simcere Phar-maceuticals Presented Six Studies on Sanbexin® at ESOC 2024
NANJING, China, May 21, 2024 /PRNewswire/ -- The 10th European Stroke Organization Congress (ESOC), held inBasel, Switzerland from May 15 to 17, 2024 , showcased six studies on Sanbexin® (Edaravone and Dexborneol Concentrated Solution for Injection) and a new dosage form of sublingual tablets unde...
2024-05-21 15:52
2043
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance
YONGIN, South Korea, May 21, 2024 /PRNewswire/ -- GC Biopharma (006280. KS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo Syndrome Type A) treatment, GC1130A. With this FDA clearance,...
2024-05-21 15:12
1974
ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance treatment through two years for adults with moderately to severely active Crohn's disease and ulcerative colitis
* Findings from the extended LIBERTY studies and associated post-hoc analysis support the long-term efficacy and safety of ZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab[1],[2] * Data from a post-hoc analysis of the LIBERTY-CD study showed that, despite affecting drug lev...
2024-05-21 12:01
2397
ILJIN SNT Co., Ltd. Calls for Board Restructure at Aurinia Pharmaceuticals
SEOUL, South Korea, May 21, 2024 /PRNewswire/ -- Fellow Aurinia Shareholders, ILJIN SNT Co., Ltd. and its affiliates (collectively, "ILJIN") is a long-term holder of more than 5% of Aurinia Pharmaceuticals Inc. ("Aurinia" or the " Company") and has been supportive of the Company's mission since 2...
2024-05-21 09:49
2072
Innovent Announces the New Drug Application of IBI311 (IGF-1R antibody) has been Accepted by the NMPA of China for Thyroid Eye Disease
SAN FRANCISCO and SUZHOU, China, May 21, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and ot...
2024-05-21 08:55
3648
Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer
* CUPID is a Phase I safety and dosimetry study of TLX592, Telix's investigational antibody-based targeted alpha therapy for prostate cancer. * Establishes proof-of-concept for Telix's proprietary RADmAb® engineered antibody platform, currently under pre-clinical evaluation for multiple cancer...
2024-05-21 07:58
2266
Pierre Fabre Laboratories announces the submission by Atara Biotherapeutics of Tabelecleucel (Tab-cel®) Biologics License Application for treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S FDA
* First Allogeneic T-Cell Therapy BLA Submission to U.S. Food and Drug Administration * The BLA is supported by data from the pivotal Phase 3 ALLELE study which was investigating Tab-cel in relapsed or refractory EBV+ PTLD following solid organ transplant (SOT) or hematopoietic cell transpla...
2024-05-20 21:30
2445
Week's Top Stories
Most Reposted
Visa Working Capital Index: Asia Pacific CFOs Call for Flexible, Digital Finance Solutions
[Picked up by 308 media titles]
2026-03-24 14:00HOY Unveils a Powerhouse Line-up of Talent for its Bold New Chapter
[Picked up by 306 media titles]
2026-03-20 09:36
MetaOptics progresses on its strategic growth and leadership transition initiatives
[Picked up by 283 media titles]
2026-03-20 08:15ART CENTRAL COMMENCES DISCOVERY-LED ELEVENTH EDITION
[Picked up by 276 media titles]
2026-03-25 16:51
Allianz Partners Australia's 2025 State of Student Healthcare Report Unpacks the Complex Realities of International Students
[Picked up by 275 media titles]
2026-03-19 09:00Most Read
Everbright Environment Announces 2025 Annual Results
2026-03-20 23:14
7561
H World Group Reports Strong Full-Year 2025 Results, Driven by Asset-light Growth
2026-03-18 21:05
7544
Ten Pao Group Announces 2025 Annual Results
2026-03-20 23:35
7375
FiEE, Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results
2026-03-21 04:05
7316